Why Beacon?
Discover how Beacon enables data-driven insight that will accelerate your drug development decisions
- Validate asset potential with insights on competitor programs, clinical outcomes, and market activity
- Explore drug design strategies and emerging targets for complex therapeutic modalities including, ADCs, Bispecifics, Cell & Gene Therapies, and RNA therapeutics; and disease areas such as Oncology and Neuroscience
- Benchmark your research with validated preclinical data, including publication summaries, and links to conference abstracts and posters
- Optimize clinical trial design by analyzing trial endpoints, outcomes, and regulatory precedents, to accelerate progression into the clinic
- Find the right partners in a competitive market, by tracking new companies, collaborations, and licensing deals, as they emerge
Join 24/25 top Pharma companies who use Beacon to accelerate and improve their drug development decisions.